Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04495699 · ClinicalTrials.gov registry record
Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 94
- Enrollment target
NCT04495699: Completed study, sponsored by Vanderbilt University Medical Center.
NCT04495699 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04495699 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
This study will assess patients who have recurrent urinary tract infections and kidney stones which are not blocking the kidney or causing other problems. Currently, we don't know if taking out these stones will improve recurrent urinary tract infections or not. Patients will make a decision with their surgeon about removing or monitoring their stone(s). Whether or not their infections continue with surgery or monitoring will be noted, and this information may help to inform future treatment decisions. The purpose of this study is to assess if treatment of these asymptomatic stones affects the rate of recurrent urinary tract infections.
Primary Outcome
• Number of UTIs, defined as positive urine culture (\>10\^5 CFU/mL of a specific organism) with symptoms. If having had surgical intervention for the stones, we will count a UTI during \>30days and \<1year after intervention so that it is not attributed to the intervention
Interventions
- OTHER None - observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2025-09-01 |
What the finished NCT04495699 record still lists
NCT04495699 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which None - observational is the first listed.
NCT04495699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04495699 about?
NCT04495699 is a clinical study titled "Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections". This study will assess patients who have recurrent urinary tract infections and kidney stones which are not blocking the kidney or causing other problems. Currently, we don't know if taking out these stones will improve recurrent urinary tract infections or not. Patients will make a decision with th...
What is the current status of trial NCT04495699?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2020-09-09. Estimated completion is 2025-09-01.
What interventions are being tested in trial NCT04495699?
The interventions under investigation include: None - observational (OTHER).
Who is sponsoring clinical trial NCT04495699?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI